FDA declines to approve Alimera's eye drug, shares tank

The U.S. Food and Drug Administration declined to approve Alimera Sciences Inc's experimental drug to treat retinal swelling in its current form, sending the biopharmaceutical company's shares down 41 percent in after-market trade.

View full post on Yahoo! Health News

, , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player

Powered by Yahoo! Answers

© 1992-2012 DC2NET™, Inc. All Rights Reserved